StonvexLoading…
StonvexStonvexStonvexCore line items from DLHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $128.16M | $68.89M | $344.50M | $83.34M |
Operating Income | $1.38M | $1.44M | $16.79M | $3.75M |
Net Income | $-3.86M | $-1.32M | $1.36M | $289.00K |
EPS (Diluted) | $-0.27 | $-0.09 | $0.09 | $0.02 |
Total Assets | $276.71M | $283.51M | $290.66M | $299.34M |
Total Liabilities | $166.44M | $171.32M | $177.71M | $185.64M |
Cash & Equivalents | $131.00K | $257.00K | $125.00K | $194.00K |
Free Cash Flow OCF − CapEx | $-1.02M | $-4.81M | $22.98M | $12.32M |
Shares Outstanding | 14.49M | 14.49M | 14.49M | 14.39M |